Last week, after one year and about 4 months of work, I consented my first patient for my clinical trial of combination axitinib and pembrolizumab for alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas.  Since this trial hit clinical trials.gov, I've had more patients come out of the woodwork with ASPS then I could have … Continue reading The one that really has to go… ASPS.